文献速递产科母胎医学

胎儿生长曲线与血红蛋白A1c水平对孕前糖尿病孕妇分娩大于胎龄儿的预测

Prediction of large-for-gestational-age infant by fetal growth charts and hemoglobin A1c level in pregnancy complicated by pregestational diabetes.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-01

本研究回顾性分析358例孕前糖尿病单胎妊娠孕妇,比较FMF、Hadlock和NICHD三种胎儿生长曲线预测分娩大于胎龄儿(LGA)的能力,并评估加入HbA1c是否改善预测性能。结果显示FMF曲线预测性能最佳,加入HbA1c后三种曲线预测能力均提高。

要点

  • FMF生长曲线预测LGA的AUC最高(0.79),优于NICHD(0.72)和Hadlock(0.75)。
  • 加入HbA1c后三种曲线预测LGA的AUC均显著提高(P<0.001)。
  • FMF曲线联合HbA1c的AUC达0.85,仍优于NICHD(0.79)和Hadlock(0.81)。

核心结论

  • 在孕前糖尿病孕妇中,FMF胎儿生长曲线预测分娩LGA的性能优于Hadlock和NICHD种族/民族特异性生长曲线。
  • 加入HbA1c测量可进一步改善所有三种生长曲线对LGA的预测。

研究设计与样本

  • 回顾性分析358例孕前糖尿病(34%为1型,66%为2型)单胎妊娠且活产无畸形的孕妇。
  • 胎儿生物测量于孕28+0至36+6周进行。
  • 主要暴露为疑似LGA(估计胎儿体重≥90百分位,分别采用Hadlock公式C、FMF和NICHD生长曲线)。
  • 主要结局为分娩LGA(出生体重≥90百分位,采用2017年美国出生数据参考)。
  • 采用AUC、敏感性、特异性、阳性预测值和阴性预测值评估预测性能。

主要发现

  • 147例(41%)分娩LGA婴儿。
  • 疑似LGA检出率:Hadlock 123例(34.4%),FMF 152例(42.5%),NICHD 152例(42.5%)。
  • 预测LGA的敏感性:FMF 77% vs NICHD 69% vs Hadlock 63%;特异性:Hadlock 86% vs NICHD 76% vs FMF 82%。
  • FMF曲线预测LGA的AUC为0.79(95%CI 0.74-0.84),显著高于NICHD的0.72(95%CI 0.68-0.77;P<0.001)和Hadlock的0.75(95%CI 0.70-0.79;P<0.01)。
  • 加入HbA1c后,三种曲线预测LGA的AUC均显著提高(P<0.001);FMF联合HbA1c的AUC为0.85(95%CI 0.81-0.90),NICHD为0.79(95%CI 0.73-0.84),Hadlock为0.81(95%CI 0.76-0.86)。

关键数值与推荐

  • FMF生长曲线预测LGA的AUC为0.79(95%CI 0.74-0.84),NICHD为0.72(95%CI 0.68-0.77),Hadlock为0.75(95%CI 0.70-0.79)。
  • FMF联合HbA1c预测LGA的AUC为0.85(95%CI 0.81-0.90),NICHD为0.79(95%CI 0.73-0.84),Hadlock为0.81(95%CI 0.76-0.86)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare the ability of three fetal growth charts (Fetal Medicine Foundation (FMF), Hadlock and National Institutes of Child Health and Human Development (NICHD) race/ethnicity-specific) to predict large-for-gestational age (LGA) at birth in pregnant individuals with pregestational diabetes, and to determine whether inclusion of hemoglobin A1c (HbA1c) level improves the predictive performance of the growth charts. METHODS: This was a retrospective analysis of individuals with Type-1 or Type-2 diabetes with a singleton pregnancy that resulted in a non-anomalous live birth. Fetal biometry was performed between 28 + 0 and 36 + 6 weeks of gestation. The primary exposure was suspected LGA, defined as estimated fetal weight ≥ 90th percentile using the Hadlock (Formula C), FMF and NICHD growth charts. The primary outcome was LGA at birth, defined as birth weight ≥ 90th percentile, using 2017 USA natality reference data. The performance of the three growth charts to predict LGA at birth, alone and in combination with HbA1c as a continuous measure, was assessed using the area under the receiver-operating-characteristics curve (AUC), sensitivity, specificity, positive predictive value and negative predictive value. RESULTS: Of 358 assessed pregnant individuals with pregestational diabetes (34% with Type 1 and 66% with Type 2), 147 (41%) had a LGA infant at birth. Suspected LGA was identified in 123 (34.4%) by the Hadlock, 152 (42.5%) by the FMF and 152 (42.5%) by the NICHD growth chart. The FMF growth chart had the highest sensitivity (77% vs 69% (NICHD) vs 63% (Hadlock)) and the Hadlock growth chart had the highest specificity (86% vs 76% (NICHD) and 82% (FMF)) for predicting LGA at birth. The FMF growth chart had a significantly higher AUC (0.79 (95% CI, 0.74-0.84)) for LGA at birth compared with the NICHD (AUC, 0.72 (95% CI, 0.68-0.77); P < 0.001) and Hadlock (AUC, 0.75 (95% CI, 0.70-0.79); P < 0.01) growth charts. Prediction of LGA improved for all three growth charts with the inclusion of HbA1c measurement in comparison to each growth chart alone (P < 0.001 for all); the FMF growth chart remained more predictive of LGA at birth (AUC, 0.85 (95% CI, 0.81-0.90)) compared with the NICHD (AUC, 0.79 (95% CI, 0.73-0.84)) and Hadlock (AUC, 0.81 (95% CI, 0.76-0.86)) growth charts. CONCLUSIONS: The FMF fetal growth chart had the best predictive performance for LGA at birth in comparison with the Hadlock and NICHD race/ethnicity-specific growth charts in pregnant individuals with pregestational diabetes. Inclusion of HbA1c improved further the prediction of LGA for all three charts. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kiefer MK, Finneran MM, Ware CA, et al. Prediction of large-for-gestational-age infant by fetal growth charts and hemoglobin A1c level in pregnancy complicated by pregestational diabetes. Ultrasound Obstet Gynecol. 2022. PMID: 36099480. doi:10.1002/uog.26071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。